Instrument Inactif

Autres langues Global Blood Therapeutics, Inc.

Actions

GBT

US37890U1088

Recherche biotechnologique et médicale

Autres langues

27/10/22	Pfizer Completes $5.4 Billion Acquisition Of Sickle Cell Disease Drug Innovator
06/10/22	BioPharma Credit Receives $175 Million From Global Blood Therapeutics Investment
06/10/22	Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from S&P Global BMI Index
06/10/22	Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from S&P TMI Index
06/10/22	Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from S&P Biotechnology Select Industry Index
05/10/22	GLOBAL BLOOD THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Regi (form 8-K)
05/10/22	Global Blood Therapeutics, Inc. Announces Cessation of Ted W. Love as Chief Executive Officer
05/10/22	Global Blood Therapeutics, Inc. Announces Executive Changes
05/10/22	Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from NASDAQ Composite Index
05/10/22	Pfizer Inc. completed the acquisition of Global Blood Therapeutics, Inc. from a group of shareholders.
04/10/22	Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from NASDAQ Biotechnology Index
30/09/22	GLOBAL BLOOD THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)
23/09/22	GLOBAL BLOOD THERAPEUTICS, INC. : Other Events (form 8-K)
16/09/22	GBT Supports the Sickle Cell Disease Treatment Centers Act of 2022
08/09/22	GBT and Sickle Cell Disease Association of America to Host 11th Annual Sickle Cell Disease Therapeutics Conference
07/09/22	Insider Sell: Global Blood Therapeutics
31/08/22	GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT
19/08/22	Insider Sell: Global Blood Therapeutics
12/08/22	Biotech stocks pin bounce back hopes on M&A boost
10/08/22	Pfizer spending spree filters to Biopharma
09/08/22	Global Blood: Q2 Earnings Snapshot
09/08/22	BioPharma Credit To Receive Loan Prepayment Following Pfizer's Takeover Of Global Blood Therapeutics
09/08/22	Pfizer scoops up Global Blood Therapeutics in $5.4bn deal
09/08/22	GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT
08/08/22	Health Care Up Amid Deal Activity -- Health Care Roundup